Clinical trial NCT00643851 - References

Type 2 Diabetes — An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Citation(s)

•   Henry RR, Murray AV, Marmolejo MH, Hennicken D, Ptaszynska A, List JF
  Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial. Int J Clin Pract. 2012 May;66(5):446-56. doi: 10.1111/j.1742-1241.2012

A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin as Initial Therapy as Compared With Dapagliflozin Monotherapy and Metformin Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Details for clinical trial NCT00643851